SV

Smith Ventures

Description

Smith Ventures is a venture capital firm.

Investor Profile

Smith Ventures has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Pre Seed (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Health Care
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Smith Ventures frequently co-invest with?

Seedcamp
Europe, England, United Kingdom, London
Co-Investments: 1
LAUNCH
North America, California, United States, San Francisco
Co-Investments: 1
MBX Capital
North America, New York, United States, New York
Co-Investments: 1
CC
North America, Florida, United States, Miami
Co-Investments: 1
Graphene Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
Founders Circle Capital
North America, California, United States, San Francisco
Co-Investments: 1
Metaplanet
Europe, Harjumaa, Estonia, Tallinn
Co-Investments: 1
AGO Partners
North America, California, United States, Los Angeles
Co-Investments: 1
Alpha Wave Global
North America, Florida, United States, Miami
Co-Investments: 1
Founders Fund
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does Smith Ventures often collaborate with?

JW
North America, Virginia, United States, Charlottesville
Shared Deals: 1
MO
North America, United States
Shared Deals: 1
BZ
North America, California, United States, Los Angeles
Shared Deals: 1
CH
Europe, United Kingdom
Shared Deals: 1
RK
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Smith Ventures?

Kappa Biosciences

San Francisco, California, United States

The next big solution for biotechnology and bioscience research

BiotechnologyLife Science
Pre SeedDec 5, 2023
Amount Raised: $8,500,000
Contraline

Charlottesville, Virginia, United States

Contraline is developing the first long-lasting, non-hormonal, reversible contraceptive for men

BiotechnologyHealth CareMedical Device
Series AOct 20, 2021
Amount Raised: $10,700,000